Action Alert: Protect Access to Compounded Peptides Federal regulators are making decisions right now that could determine the future of peptide based therapies in the U.S. Compounded peptides such as BPC 157 and epitalon FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn BPC157, TB500, GHK Cu FDA Compounded "semaglutide" is not FDA approved semaglutide.com The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York